3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[1-(4-fluoro-1-methylindazol-5-yl)-2-methylimidazol-4-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one
C49H50F2N10O4 — CID 177288755
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[1-(4-fluoro-1-methylindazol-5-yl)-2-methylimidazol-4-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one
3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[1-(4-fluoro-1-methylindazol-5-yl)-2-methylimidazol-4-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one (PubChem CID 177288755) has the molecular formula C49H50F2N10O4 and a molecular weight of 881.00 g/mol. Its IUPAC name is 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[1-(4-fluoro-1-methylindazol-5-yl)-2-methylimidazol-4-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one.
Molecular Properties
| Compound Name | 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[1-(4-fluoro-1-methylindazol-5-yl)-2-methylimidazol-4-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one |
|---|---|
| PubChem CID | 177288755 |
| Molecular Formula | C49H50F2N10O4 |
| Molecular Weight | 881.00 g/mol |
| Exact Mass | 880.40 |
| IUPAC Name | 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[1-(4-fluoro-1-methylindazol-5-yl)-2-methylimidazol-4-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one |
| SMILES | Cc1cc(-n2nc3c(c2-c2cn(-c4ccc5c(cnn5C)c4F)c(C)n2)[C@H](C)N(C(=O)c2cc4cc([C@H]5CCOC(C)(C)C5)ccc4n2[C@@]2(c4noc(=O)[nH]4)C[C@@H]2C)CC3)cc(C)c1F |
| InChI | InChI=1S/C49H50F2N10O4/c1-25-17-33(18-26(2)42(25)50)61-44(36-24-59(29(5)53-36)39-12-11-38-34(43(39)51)23-52-57(38)8)41-28(4)58(15-13-35(41)55-61)45(62)40-20-32-19-30(31-14-16-64-48(6,7)22-31)9-10-37(32)60(40)49(21-27(49)3)46-54-47(63)65-56-46/h9-12,17-20,23-24,27-28,31H,13-16,21-22H2,1-8H3,(H,54,56,63)/t27-,28-,31-,49-/m0/s1 |
| InChIKey | DONWKQZSILDJEG-RUTBYHEKSA-N |
| XLogP | 8.66 |
| TPSA | 146.82 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 65 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 881.00 |
| LogP ≤ 5 | 8.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177288755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.